Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of ...
Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...
Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdomin ...
Boston Scientific announced FDA clearance for the “Any Day Dosing” feature on the company’s TheraSphere 360 ytt ...
Three-year outcomes from the PERFORMANCE II trial studying the Neuroguard Integrated Embolic Protection (IEP) 3-in-1 Carotid Sten ...
Cook Medical announced it has selected Indiana University (IU) in Indianapolis, Indiana, as one of the first Interventional ...
IceCure Medical Ltd. announced that the FDA has approved the study design for the ChoICE trial, the company’s postmarketing ...
Toro Neurovascular announced FDA 510(k) clearance and commercial introduction of the Toro 88 superbore catheter, a ...
BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...
VentureMed Group, Inc. announced it is now doing business as (DBA) Flex Vascular. The medical device company specializes in ...
Royal Philips announced the launch of Rembra, its next-generation radiology CT system designed for acute and high-demand ...
VS3 Medical, Inc. announced it has commenced enrollment in an international first-in-human (FIH) study evaluating the VS3 Med ...